acquired by www.luminexcorp.com
EraGen BioSciences Inc.
EraGen products drive essential molecular diagnostics to market faster
by providing clinical laboratories and medical researchers with the
next generation of easy-to-use genetic testing for critical disease
states including infectious diseases, genetics and cancer. Madison-based
Eragen has raised over $20 million in venture capital from investors
including Novartis Ventures, First Analysis Corp, Prolog Ventures,
Stonehenge Capital and Continuum Investment Partners.
Eso-Technologies is an early stage company developing an esophageal
cardiac monitoring device for surgical and critical care applications.
This new device is designed to replace the industry standard and
more invasive pulmonary artery catheter (PAC), and offer greater
capabilities, improved diagnostic specificity, greatly enhanced safety,
and significant cost advantages. Wisconsin-based, Eso-Technologies
has developed and tested their product prototypes, completed a clinical
protocol, and engaged three clinical partners to complete early trials.
The company's $1MM Series A Preferred was led by DaneVest with significant
participation by Phenomenelle Angels Fund.
HarQen is a web telephony company that leverages its voice to web
audio technology and social networking platform to develop smart,
easy-to-use business applications that solve real world problems.
From a consumer standpoint, using HarQen’s technology is as
easy as leaving a voicemail. The company's first two products are
VoiceScreener and Comic Wonder. Milwaukee-based HarQen's Round One
and bridge financing rounds were led by the Phenomenelle Angel Fund,
with participation by Wisconsin Investment Partners and Women Angels.
acquired by www.cdcsoftware.com
iDC is a leading developer of Fund Accounting software for government
and not-for-profit organizations. iDCís web-based, scalable
products are designed for rapid implementation, seamless integration,
and can be tailored to fit specific needs of IT, finance and elected
officials. They enhance emergency preparedness, government continuity
and disaster recovery. iDC recently gained national recognition as
recipient of the NAWBO/Wells Fargo Trailblazer Award for Technology
Innovation and the 2005 Torch Award for Marketplace Ethics from the
Better Business Bureau of Northern Illinois. Additionally, the Illinois
Department of Commerce and Economic Opportunity awarded iDC a grant
to enhance homeland security efforts. iDC is based in Chicago. Phenomenelle
Angel Fund was iDC's first institutional investor.
Madison-based Kiio manufactures a wireless sensor for physical therapists that attaches to an exercise band or rope and measures the force with which the band is being pulled by a patient. Kiio is a spinoff of Lifeline USA, a leading fitness equipment company started in 1973.
Shanghai, China-based Meihui China Software develops intelligent traffic management systems based upon multi-source data. Meihui is the market-leading provider of regional traffic data in China and has an extensive patent portfolio.
Michelle's Miracle, Inc.
Michelle’s Miracle® creates, markets and distributes branded
products made from tart cherry concentrate as nutritional supplements
in the U.S. and Canada through direct, wholesale and private label
channels targeted at consumers seeking natural and whole food based
solutions for overall health and chronic conditions such as joint
pain and arthritis. Leland, Michigan-based Michelle's Miracle's Series
A round was led by the Phenomenelle Angels Fund. Seed investor, Fisher
Properties of Indiana, reinvested in the company's Series A.
Biomarker Discovery Inc.
Stemina Cell Discovery discovers and validates small molecules as
biomarkers for high-throughput drug screening and disease diagnostics
using an all human system comprised of stem cells and the Company's
proprietary metabolomics platform. Metabolomics enables the discovery
of small molecules that can be used as candidate biomarkers of disease
and pharmacological efficacy or toxicity. The human embryonic stem
cell metabolome is a source of candidate biomarkers to predict, diagnose
or measure the progress of disease or toxic response. Stemina provides
compound screening and diagnostic development for the pharmaceutical
and biotechnology industries and academia under contract services
or joint discovery agreements. Stemina is based in Madison, WI. Phenomenelle
Angels Fund co-invested with Wisconsin Investment Partners and DaneVest
Third Solutions, Inc.
Third Solutions provides real-time access to all retail receipts
through a single web interface at myreceipts.com. MyReceipts™ offers
retailers and marketers access to a revolutionary personalized marketing
engine fully driven by the use of Digital Receipts at the Point of
Sale. This patent pending solution delivers receipts, coupons, rebates
and product data in a fully paperless environment all while conserving
TrafficCast International is a leading provider of digital traffic
data, with patented software and predictive models to produce route-specific
real-time traffic information and travel time forecasts for traditional
and emerging traffic information markets. TrafficCast International
recently deployed the world's largest cell probe data collection
system in Shanghai. The company is based in Madison, Wisconsin and
has a branch office in Shanghai. Phenomenelle Angels Fund co-led
TrafficCast's Series A round together with NEW Capital Fund and Ceres